Eosinophilic drug reactions detected by a prospective pharmacovigilance programme in a tertiary hospital.
Elena RamírezNicolás Medrano-CasiqueHoi Y TongTeresa BellónRosario CabañasAna FiandorJessica González-RamosPedro HerranzElena TrigoMario MuñozAlberto M BorobiaAntonio J CarcasJesús FríasPublished in: British journal of clinical pharmacology (2016)
Half (53.3%, 64/120 cases) of symptomatic EDRs were potential DRESS. The main predictor of severity of EDR was an early severe eosinophilia.